SI
KRYS icon

Scout Investments’s Krystal Biotech KRYS Stock Holding History

Scout Investments’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$7.17M Sell
40,100
-6,453
-14% -$1.24M 0.19% 146
2024
Q2 		$8.55M Sell
46,553
-4,424
-9% -$743K 0.23% 141
2024
Q1 		$8.98M Buy
+50,977
New +$7.08M 0.22% 142

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Scout Investments's KRYS Position: Q3 2024 in Review

Scout Investments reduced its Krystal Biotech (KRYS) stake by 14% in Q3 2024, selling an estimated $1.24M and leaving 40,100 shares worth $7.17M. The position accounts for 0.19% of the portfolio, ranked #146.

Scout Investments first reported a position in KRYS in Q1 2024 and has held it in 3 quarters since. The position peaked at $8.98M in Q1 2024. 283 funds tracked by Wall St. Rank hold KRYS as of Q3 2024.

  • Scout Investments held 40,100 shares of Krystal Biotech worth $7.17M as of Q3 2024.
  • Scout Investments sold 6,453 Krystal Biotech shares in Q3 2024, an estimated $1.24M.
  • Krystal Biotech made up 0.19% of Scout Investments's portfolio in Q3 2024, its #146 holding.
  • Scout Investments first reported a position in Krystal Biotech in Q1 2024 and has held it in 3 quarters since.
  • Scout Investments's Krystal Biotech position peaked at $8.98M in Q1 2024.
  • 283 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2024.

Based on Scout Investments's 13F filing for Q3 2024, filed 12 Nov 2024.